Total Payments
$2,033
2024 Payments
$597.80
Companies
16
Transactions
103
Medicare Patients
10,707
Medicare Billing
$5.8M
Payment Breakdown by Category
Food & Beverage$2,013 (99.0%)
Gifts$19.40 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,013 | 102 | 99.0% |
| Gift | $19.40 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $526.48 | 23 | $0 (2024) |
| Alimera Sciences, Inc. | $342.87 | 21 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $261.70 | 18 | $0 (2024) |
| Genentech USA, Inc. | $196.33 | 10 | $0 (2024) |
| ABBVIE INC. | $169.88 | 7 | $0 (2024) |
| Astellas Pharma US Inc | $159.46 | 5 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $107.98 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $85.66 | 5 | $0 (2021) |
| Allergan, Inc. | $35.66 | 2 | $0 (2021) |
| Coherus Biosciences Inc. | $25.97 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $597.80 | 26 | Regeneron Healthcare Solutions, Inc. ($199.36) |
| 2023 | $561.57 | 29 | Apellis Pharmaceuticals, Inc. ($161.05) |
| 2022 | $401.45 | 21 | Regeneron Healthcare Solutions, Inc. ($103.13) |
| 2021 | $139.76 | 8 | Alimera Sciences, Inc. ($42.64) |
| 2020 | $95.70 | 5 | Novartis Pharmaceuticals Corporation ($36.23) |
| 2019 | $165.90 | 10 | Alimera Sciences, Inc. ($70.16) |
| 2018 | $52.05 | 3 | Vyera Pharmaceuticals, LLC ($23.52) |
| 2017 | $18.60 | 1 | Genentech USA, Inc. ($18.60) |
All Payment Transactions
103 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: EYE CARE | ||||||
| 10/22/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 10/15/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Ophthalmology | ||||||
| 10/01/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $31.37 | General |
| Category: Ophthalmology | ||||||
| 09/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: EYE CARE | ||||||
| 08/06/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 07/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/02/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/26/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Ophthalmology | ||||||
| 06/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/12/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: EYE CARE | ||||||
| 06/11/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 06/05/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Ophthalmology | ||||||
| 05/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/10/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.58 | General |
| Category: Ophthalmology | ||||||
| 04/03/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/26/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Ophthalmology | ||||||
| 03/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/14/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 02/08/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/10/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,353 | 25,374 | $3.5M | $1.5M |
| 2022 | 17 | 2,886 | 12,035 | $3.8M | $1.6M |
| 2021 | 19 | 2,889 | 7,445 | $3.3M | $1.4M |
| 2020 | 16 | 2,579 | 6,928 | $2.9M | $1.2M |
Total Patients
10,707
Total Services
51,782
Medicare Billing
$5.8M
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 76 | 19,020 | $871,687 | $555,443 | 63.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 122 | 794 | $992,500 | $551,476 | 55.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 682 | 1,625 | $406,250 | $133,962 | 33.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 329 | 1,251 | $460,600 | $101,960 | 22.1% |
| 92134 | Imaging of retina | Office | 2023 | 734 | 1,782 | $302,940 | $52,778 | 17.4% |
| J3490 | Unclassified drugs | Office | 2023 | 16 | 21 | $72,700 | $38,894 | 53.5% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 12 | 161 | $69,001 | $24,630 | 35.7% |
| J3590 | Unclassified biologics | Office | 2023 | 127 | 409 | $104,750 | $20,794 | 19.9% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 21 | 21 | $111,573 | $18,045 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 143 | 143 | $46,475 | $15,599 | 33.6% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 12 | 13 | $67,069 | $8,385 | 12.5% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 34 | 87 | $22,000 | $5,798 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 30 | $4,500 | $1,661 | 36.9% |
| 92250 | Photography of the retina | Office | 2023 | 17 | 17 | $2,550 | $391.96 | 15.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 170 | 1,166 | $1.5M | $840,214 | 57.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 758 | 1,750 | $437,575 | $151,492 | 34.6% |
| J3590 | Unclassified biologics | Office | 2022 | 169 | 535 | $311,500 | $149,326 | 47.9% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 38 | 4,200 | $192,486 | $125,334 | 65.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 379 | 1,451 | $526,750 | $119,718 | 22.7% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2022 | 11 | 282 | $126,900 | $69,424 | 54.7% |
| 92134 | Imaging of retina | Office | 2022 | 822 | 1,966 | $334,220 | $58,934 | 17.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 209 | 209 | $67,925 | $23,465 | 34.5% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 68 | 198 | $50,250 | $13,444 | 26.8% |
| 67041 | Removal of membrane of retina | Facility | 2022 | 15 | 15 | $79,695 | $13,108 | 16.4% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2022 | 14 | 15 | $79,695 | $12,837 | 16.1% |
About Dr. Robert Wenz, M.D
Dr. Robert Wenz, M.D is a Ophthalmology healthcare provider based in Canton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1639172984.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Wenz, M.D has received a total of $2,033 in payments from pharmaceutical and medical device companies, with $597.80 received in 2024. These payments were reported across 103 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,013).
As a Medicare-enrolled provider, Wenz has provided services to 10,707 Medicare beneficiaries, totaling 51,782 services with total Medicare billing of $5.8M. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Retina Specialist
- Location Canton, OH
- Active Since 05/31/2005
- Last Updated 05/11/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1639172984
Products in Payments
- EYLEA (Biological) $420.77
- OZURDEX (Drug) $205.54
- Syfovre (Drug) $191.69
- ILUVIEN (Drug) $178.16
- EYLEA HD (Biological) $105.71
- YUTIQ (Drug) $102.75
- Vabysmo (Drug) $95.40
- Izervay (Drug) $92.77
- Iluvien (Drug) $85.36
- DEXYCU (Drug) $84.58
- BEOVU (Drug) $66.27
- Lucentis (Biological) $60.62
- VABYSMO (Drug) $40.31
- Cimerli (Biological) $25.97
- XIPERE (Drug) $23.95
- Daraprim Tablet 25mg (Drug) $23.52
- None Specified (Medical Supply) $19.40
- BROMSITE (Drug) $17.62
- ACTHAR (Biological) $14.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Canton
Paul Turgeon, Md, MD
Ophthalmology — Payments: $14,884
Ophthalmology $14,884
Cameron Johnson, M.d, M.D
Ophthalmology — Payments: $6,348
Ophthalmology $6,348
Arnold Nothnagel, Do, DO
Ophthalmology — Payments: $4,161
Ophthalmology $4,161
Dr. Sophia Pachydaki, Md, MD
Ophthalmology — Payments: $3,837
Ophthalmology $3,837
Dr. William Marks, M.d, M.D
Ophthalmology — Payments: $3,578
Ophthalmology $3,578
Philip Roholt, M.d, M.D
Ophthalmology — Payments: $3,425
Ophthalmology $3,425